These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2887901)

  • 41. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.
    Furuhashi M; Moniwa N; Mita T; Fuseya T; Ishimura S; Ohno K; Shibata S; Tanaka M; Watanabe Y; Akasaka H; Ohnishi H; Yoshida H; Takizawa H; Saitoh S; Ura N; Shimamoto K; Miura T
    Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
    Jankova T; Tchankova P; Nenov D
    Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure.
    Yang HY; Chen JR; Chang LS
    Hypertens Res; 2008 May; 31(5):957-63. PubMed ID: 18712051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension.
    Dux S; Aron N; Boner G; Carmel A; Yaron A; Rosenfeld JB
    Isr J Med Sci; 1984 Dec; 20(12):1138-42. PubMed ID: 6097566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Angiotensin-converting enzyme gene polymorphism].
    Tabara Y; Miki T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():432-8. PubMed ID: 16895211
    [No Abstract]   [Full Text] [Related]  

  • 48. Intrarenal Angiotensin-Converting Enzyme: the Old and the New.
    Culver S; Li C; Siragy HM
    Curr Hypertens Rep; 2017 Sep; 19(10):80. PubMed ID: 28929450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High prevalence of ACE DD genotype among north Indian end stage renal disease patients.
    Tripathi G; Dharmani P; Khan F; Sharma RK; Pandirikkal V; Agrawal S
    BMC Nephrol; 2006 Oct; 7():15. PubMed ID: 17042963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lisinopril and renal failure.
    Heeg JE; de Jong PE; de Zeeuw D
    Lancet; 1989 Apr; 1(8642):846. PubMed ID: 2564931
    [No Abstract]   [Full Text] [Related]  

  • 51. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets.
    Treml B; Neu N; Kleinsasser A; Gritsch C; Finsterwalder T; Geiger R; Schuster M; Janzek E; Loibner H; Penninger J; Loeckinger A
    Crit Care Med; 2010 Feb; 38(2):596-601. PubMed ID: 19851091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent findings on the role of the kidney in the physiopathology of arterial hypertension].
    Santucci A; Balsona F
    Recenti Prog Med; 1982 Jun; 72(6):722-43. PubMed ID: 6183721
    [No Abstract]   [Full Text] [Related]  

  • 53. ACE-inhibitors in severe hypertension.
    Herlitz H
    Scand J Urol Nephrol Suppl; 1984; 79():73-9. PubMed ID: 6089321
    [No Abstract]   [Full Text] [Related]  

  • 54. The kidney and hypertension.
    Grenfell RF
    Compr Ther; 1975 Jun; 1(2):39-41. PubMed ID: 177245
    [No Abstract]   [Full Text] [Related]  

  • 55. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of rapid lowering of blood pressure on renal function in hypertensives with renal failure.
    Dash SC; Chugh KS; Nath R; Wahi PL
    Indian J Med Res; 1975 Jul; 63(7):902-9. PubMed ID: 1213791
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients].
    Fedor R; Kovács DÁ; Lőcsey L; Fagyas M; Asztalos L; Tóth A
    Orv Hetil; 2016 Jun; 157(24):938-45. PubMed ID: 27263433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.
    Li X; Du Y; Du Y; Huang X
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.
    Zoccali C
    J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.